Targeting the common β-chain p40 of IL-12/IL-23 and inhibiting IL-12/IL-23 signaling can reduce pathogenic microglia, decrease Aβ accumulation, and reverse the memory defects in an AD animal model [19]. The gene discussed is IL23A; the disease is Alzheimer disease.